Industry News
The Roles Of The HRRM2 Subunit In Colorectal Cancer And UV-Induced DNA Damage Repair
Sep 20, 2012
Colorectal cancer (CRC) is the leading cause of cancer-related death worldwide. In addition, the incidence and mortality rates of colorectal cancer are on the rise. Recently, metabolic genes have received increasing and specific attention due to their potential role in carcinogenesis... Read More
Moderate Drinking May Increase Risk For Certain Cancers
Sep 20, 2012
The majority of observational studies have shown that alcohol intake, especially heavy drinking, increases a number of upper-aero-digestive tract (UADT) and other cancers, and even moderate drinking is associated with a slight increase in the risk of breast cancer... Read More
Powerful Chemotherapy For Prostate Cancer Treatment's Underlying Mechanism Revealed
Sep 20, 2012
Study Suggests Role of Taxane-Based Chemotherapy Drugs May Be Underestimated and Should Be Re-examined to Improve the Drug's Effectiveness The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research... Read More
Snake Venom Could Unlock Drug Discoveries For Cancer, Diabetes
Sep 20, 2012
A new revelation has been discovered, claiming that toxins in snake venom could potentially open doors to cutting-edge drugs being able to treat severe medical conditions, such as diabetes, high blood pressure, and cancer... Read More
Sorafenib-Refractory Liver Cancer Treatment Produces Positive Clinical Data
Sep 20, 2012
Key Clinical Endpoints Met: JX594/TG6006 can be safely and efficiently delivered through systemic route and standard-of-care Sorafenib can be safely administered sequentially after JX594/TG6006, opening door to new clinical perspectives Jennerex, Inc... Read More
Assessment Of HPV DNA Alone Insufficient To Identify HPV-Driven Head And Neck Cancers
Sep 20, 2012
Human papillomavirus (HPV) DNA positivity alone, particularly when assessed using polymerase chain reaction methods, is a poor biomarker for HPV-driven head and neck cancers, according to two studies published in Cancer Research, a journal of the American Association for Cancer Research... Read More
Development Of Whole Exome Sequencing Analysis Of FFPE DNA Samples To Boost Biomedicine
Sep 20, 2012
BGI Tech Solutions Co., Ltd. (the "BGI Tech"), a subsidiary company of BGI, have announced that they have achieved whole exome sequencing analysis of total degraded DNA as low as 200 ng from formalin fixed paraffin embedded (FFPE) samples... Read More
New Substance Has Potential To Induce Apoptosis In Cancer Cells
Sep 20, 2012
The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective, the cancer cells can acquire the ability to evade apoptosis and become more resistant to therapy... Read More
Least Aggressive Form Of Breast Cancer Still Poses Mortality Risk Years Later
Sep 20, 2012
Women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease more than 10 years after diagnosis, according to a Kaiser Permanente study published in the journal Cancer Epidemiology, Biomarkers & Prevention... Read More
Blood Clots Unlikely To Be Prevented By Statins
Sep 20, 2012
Despite previous studies suggesting the contrary, statins (cholesterol-lowering drugs) may not prevent blood clots (venous thrombo-embolism) in adults, according to a large analysis by international researchers published in this week's PLOS Medicine... Read More
Previous Page Next Page